Physician Photo

Kathleen E. Corey, MD, MPH

Director, MGH Fatty Liver Clinic, MGH Gastrointestinal Unit

Co-Director, MGH Weight Center

Director of Clinical and Translational Research, MGH Weight Center

Kathleen E Corey, MD, MPH, MMSc is an Instructor in Medicine at Harvard Medical School and Director of the MGH Fatty Liver Clinic in the MGH Gastrointestinal Unit. Dr. Corey is also the Co-Director of the MGH Weight Center.

Departments
Gastroenterology
Department of Medicine

Specialties

  • Digestive Healthcare Center
  • Weight Center
  • Liver Center
  • Transplant Center
  • Liver Transplant
Clinical Interests
Non-alcoholic fatty liver disease
Hepatitis C
Hepatitis B
Primary Biliary Cirrhosis
Primary sclerosing cholangitis
Liver transplant
Hemochromatosis
Alpha-1-anti-trypsin disease
Cirrhosis
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, Duke University School of Medicine
MMSc, Harvard University
Residency, Massachusetts General Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Gastroenterology, American Board of Internal Medicine
Transplant Hepatology, American Board of Internal Medicine
Gender
Female
Patient Gateway
Yes, learn more
Patient Age Group
Adult
Accepting New Patients
Yes

BiographyKathleen E Corey, MD, MPH, MMSc is an Instructor in Medicine at Harvard Medical School and Director of the MGH Fatty Liver Clinic in the MGH Gastrointestinal Unit. Dr. Corey is also the Co-Director of the MGH Weight Center.

Dr. Corey's clinical interests include all areas of hepatology including non-alcoholic fatty liver disease (NAFLD), viral hepatitis including hepatitis B, C and D infection, autoimmune hepatitis, cholestatic liver disease including primary biliary cirrhosis and primary sclerosing cholangitis. In addition, Dr. Corey treats patients with hereditary forms of liver disease including hemochromatosis and alpha-1-antitrypsin disease. Dr. Corey is also a transplant hepatologist and evaluates patients in need of liver transplantation and cares for patients after liver transplant. Dr. Corey also performs endoscopies including diagnostic and therapeutic upper endoscopy and colonoscopy.

Dr. Corey's research focuses on non-alcoholic fatty liver disease and the development of non-invasive biomarkers for the diagnosis and monitoring of NAFLD.  Dr. Corey has lectured regionally and nationally on NAFLD.

http://articles.chicagotribune.com/2012-04-18/health/sc-health-0418-fatty-liver-20120418_1_nonalcoholic-fatty-liver-disease-nonalcoholic-steatohepatitis-obese-people

ResearchDr. Corey's research focuses on lipid metabolism in patients with steatosis and steatohepatitis as well as the development of non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Dr. Corey also studies the interaction between obstructive sleep apnea and fatty liver disease. Dr. Corey also participates in numerous clinical trials including studies for hepatitis B and C treatment and post-transplant prevention of hepatitis C infection.

Weight Center restructures

ACCORDING TO RECENT DATA from the National Health and Nutrition Examination Survey, approximately one-third of U.S. adults and 17 percent of children and adolescents aged 2 to 19 years are obese.

The link between obesity and nonalcoholic fatty liver disease

Kathleen Corey, MD, director of the Massachusetts General Hospital Fatty Liver Clinic and co-director of the Mass General Weight Center, discusses the connection between obesity and nonalcoholic fatty liver disease (NAFLD).

Threat grows from liver illness tied to obesity

Kathleen Corey, MD, director of the Massachusetts General Hospital Fatty Liver Clinic and co-director of the Mass General Weight Center, discusses the link between obesity and the rise in liver diseases such as nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease.

Gastroenterology Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-724-1685
Fax: 617-724-5997